Helen Clark

Regional Director, Europe
Full contact info

Experience

Forty Seven Agrees to Sell to Gilead for $4.9 Billion

March 2, 2020

Cooley advised publicly traded clinical-stage immuno-oncology company Forty Seven on its agreement to sell to Gilead for $4.9 billion in all cash. Partners Jamie Leigh, Ben Beerle, Eric Jensen and John McKenna led the Cooley team advising Forty Seven on the transaction, which is expected close in Q2.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Eric Jensen
Vice Chair, Palo Alto
John McKenna
Partner, Palo Alto
Rowook Park
Partner, San Diego
Natalie Karam
Partner, Palo Alto
Matthew D. Silverman
Special Counsel, San Diego
Kealan Santistevan
Associate, Palo Alto
Rajdeep Roger Bains
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Stephanie Gentile
Partner, New York
Todd Gluth
Partner, San Diego
Jacqueline Grise
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Rubin Waranch
Associate, Washington, DC
Helen Clark
Regional Director, Europe, London
Jessica Dallas
Associate, Palo Alto

Related Practices & Industries